Study to Assess the Safety, Tolerability and Pharmacokinetics of Single Ascending Oral Doses of J147
- First Posted Date
- 2019-02-12
- Last Posted Date
- 2020-09-03
- Lead Sponsor
- Abrexa Pharmaceuticals, Inc.
- Target Recruit Count
- 64
- Registration Number
- NCT03838185
- Locations
- 🇺🇸
Vince & Associates Clinical Research, Inc., Overland Park, Kansas, United States
© Copyright 2025. All Rights Reserved by MedPath